Download PDF
Semin Neurol 2005; 25(2): 229-237
DOI: 10.1055/s-2005-871331
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Rehabilitation Management of Peripheral Neuropathy

Gregory T. Carter1
  • 1Department of Rehabilitation Medicine, University of Washington, School of Medicine, Seattle, Washington
Further Information

Publication History

Publication Date:
03 June 2005 (online)

    Permissions and Reprints

ABSTRACT

The goals of rehabilitation for patients with peripheral neuropathy are to maximize and prolong independent and safe locomotion and function, inhibit physical deformity, and provide access to full integration into society. The services of multiple disciplines are required to fully achieve these goals and include physicians, nurses, therapists, orthotists, social and vocational counselors, and psychologists. Treatment is goal-oriented, using various modalities including exercise, bracing, adaptive equipment, medication, and surgery.

KEYWORDS

Peripheral neuropathy - rehabilitation - neuropathic pain - orthotics - neuromuscular disease

REFERENCES

  • 1 Emery A H. Population frequencies of inherited neuromuscular diseases: a world survey.  Neuromuscul Disord. 1991;  1 19-29
    CrossrefPubMedGoogle Scholar
  • 2 Carter G T, Abresch R T, Fowler W M et al.. Profiles of neuromuscular disease: hereditary motor and sensory neuropathy, types I and II.  Am J Phys Med Rehabil. 1995;  74 S140-S149
    CrossrefPubMedGoogle Scholar
  • 3 Carter G T. Neuromuscular disorders. In: Dell Orto AE, Marinelli RP Encyclopedia of Disability and Rehabilitation. New York; Simon & Schuster MacMillan 1995: 509-515
    Google Scholar
  • 4 Fowler W M, Abresch R T, Aitkens S A, Carter G T. Impairment and disability profiles of neuromuscular diseases: design of the protocol.  Am J Phys Med Rehabil. 1995;  74 62-69
    PubMedGoogle Scholar
  • 5 Fowler W M, Carter G T, Kraft G H. Role of physiatry in the management of neuromuscular disease.  Phys Med Rehabil Clin N Am. 1998;  9 1-8
    PubMedGoogle Scholar
  • 6 Carter G T. e-Medicine: rehabilitation management of neuromuscular disease. Physical Medicine and Rehabititation. http://Available at: www.emedicine.com/pmr/topic 233.htm
    Google Scholar
  • 7 Carter G T, England J D, Hecht T W, Han J, Weydt P, Chance P. Electrodiagnosis of hereditary motor and sensory neuropathies.  Phys Med Rehabil Clin N Am. 2003;  14 347-363
    PubMedGoogle Scholar
  • 8 Carter G T, England J D, Chance P F. Charcot-Marie-Tooth disease: electrophysiology, molecular biology, and clinical management.  IDrugs. 2004;  7 151-159
    PubMedGoogle Scholar
  • 9 Ionasescu V V. Charcot-Marie-Tooth neuropathies: from clinical description to molecular genetics.  Muscle Nerve. 1995;  18 267-275
    PubMedGoogle Scholar
  • 10 Lindeman E, Leffers P, Reulen J, Spaans F, Drukker J. Quadriceps strength and timed motor performances in myotonic dystrophy, Charcot-Marie-Tooth disease, and healthy subjects.  Clin Rehabil. 1998;  12 127-135
    CrossrefPubMedGoogle Scholar
  • 11 Lindeman E, Leffers P, Reulen J et al.. Reduction of knee torques and leg-related functional abilities in hereditary motor and sensory neuropathy.  Arch Phys Med Rehabil. 1994;  75 1201-1205
    CrossrefPubMedGoogle Scholar
  • 12 Kilmer D D, Aitkens S G, Wright N C et al.. Simulated work performance tasks in persons with neuropathic and myopathic weakness.  Arch Phys Med Rehabil. 2000;  81 938-943
    CrossrefPubMedGoogle Scholar
  • 13 Aitkens S G, McCrory M A, Kilmer D D, Bernauer E M. Moderate resistance exercise program: its effects in slowly progressive neuromuscular disease.  Arch Phys Med Rehabil. 1993;  74 711-715
    CrossrefPubMedGoogle Scholar
  • 14 Kilmer D D, McCrory M A, Wright N C, Aitkens S G, Bernauer E M. The effect of a high resistance exercise program in slowly progressive neuromuscular disease.  Arch Phys Med Rehabil. 1994;  75 560-563
    PubMedGoogle Scholar
  • 15 Kilmer D D. Response to aerobic exercise training in humans with neuromuscular disease.  Am J Phys Med Rehabil. 2002;  81 S148-S150
    CrossrefPubMedGoogle Scholar
  • 16 Kilmer D D. Response to resistive strengthening exercise training in humans with neuromuscular disease.  Am J Phys Med Rehabil. 2002;  81 S121-S126
    CrossrefPubMedGoogle Scholar
  • 17 Kilmer D D. The role of exercise in neuromuscular disease.  Phys Med Rehabil Clin N Am. 1998;  9 115-125
    PubMedGoogle Scholar
  • 18 Lindeman E, Leffers P, Spaans F et al.. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial.  Arch Phys Med Rehabil. 1995;  76 612-620
    PubMedGoogle Scholar
  • 19 Kilmer D D, Mcrory M A, Wright N C et al.. Hand held dynamometry reliability in persons with neuropathic weakness.  Arch Phys Med Rehabil. 1997;  78 1364-1368
    CrossrefPubMedGoogle Scholar
  • 20 Carter G T, Kikuchi N, Abresch R T, Walsh S A, Horasek S, Fowler W M. Effects of exhaustive concentric and eccentric exercise on murine skeletal muscle.  Arch Phys Med Rehabil. 1994;  75 555-559
    PubMedGoogle Scholar
  • 21 Carter G T, Abresch R T, Fowler W M. Adaptations to exercise training and contraction-induced muscle injury in animal models of neuromuscular disease.  Am J Phys Med Rehabil. 2002;  81(suppl) S151-S161
    CrossrefPubMedGoogle Scholar
  • 22 Breslin E, Booth J, Lord B et al.. Respiratory responses to unsupported arm exercise (UAE) in Charcot Marie Tooth (CMT) [abstract]. American Thoracic Society.  Am Rev Respir Dis. 1993;  147 532A
    PubMedGoogle Scholar
  • 23 Breslin E H, Carter G T, Mercer K, Bonekat H W, Lee K. Fatigue in patients with Charcot-Marie-Tooth [abstract].  Arch Phys Med Rehabil. 1993;  74 A1256-A1257
    PubMedGoogle Scholar
  • 24 Videler A J, Beelen A, Aufdemkampe G et al.. Hand strength and fatigue in patients with hereditary motor and sensory neuropathy (types I and II).  Arch Phys Med Rehabil. 2002;  83 1274-1278
    CrossrefPubMedGoogle Scholar
  • 25 Carter G T, Kilmer D D, Szabo R M, McDonald C M. Focal posterior interosseus neuropathy in the presence of hereditary motor and sensory neuropathy, type I.  Muscle Nerve. 1996;  19 644-648
    PubMedGoogle Scholar
  • 26 McDonald C M. Limb contracture in progressive neuromuscular disease and the role of stretching, orthotics, and surgery.  Phys Med Rehabil Clin N Am. 1998;  9 187-212
    PubMedGoogle Scholar
  • 27 Paulson L E, Kilmer D D. Orthotic management in peripheral neuropathy.  Phys Med Rehabil Clin N Am. 2001;  12 433-445
    PubMedGoogle Scholar
  • 28 Boninger M L, Leonard Jr J A. Use of bivalved ankle-foot orthosis in neuropathic foot and ankle lesions.  J Rehabil Res Dev. 1996;  33 16-19
    PubMedGoogle Scholar
  • 29 Bean J, Walsh A, Frontera W. Brace modification improves aerobic performance in Charcot-Marie-Tooth disease: a single-subject design.  Am J Phys Med Rehabil. 2001;  80 578-582
    CrossrefPubMedGoogle Scholar
  • 30 Perry J. Normal and pathological gait. In: Goldberg B, Hsu JD Atlas of Orthoses and Assistive Devices. 3rd ed. St. Louis; Mosby 1997: 295-304
    Google Scholar
  • 31 Helm P A, Walker S C, Pullium G. Total contact casting in diabetics with neuropathic foot ulcerations.  Arch Phys Med Rehabil. 1984;  65 691-695
    PubMedGoogle Scholar
  • 32 Helm P A, Walker S C, Pullium G F. Recurrence of neuropathic ulceration following healing in a total contact cast.  Arch Phys Med Rehabil. 1991;  72 967-975
    PubMedGoogle Scholar
  • 33 King S, Thomas J J, Rice M S. The immediate and short-term effects of a wrist extension orthosis on upper-extremity kinematics and range of shoulder motion.  Am J Occup Ther. 2003;  57 517-524
    PubMedGoogle Scholar
  • 34 Schon L C, Easley M E, Weinfeld S B. Charcot neuroarthropathy of the foot and ankle.  Clin Orthop. 1998;  349 116-117
    PubMedGoogle Scholar
  • 35 Sella E J, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient.  J Foot Ankle Surg. 1999;  38 34-45
    CrossrefPubMedGoogle Scholar
  • 36 Sinacore D R, Withrington N C. Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle.  J Orthop Sports Phys Ther. 1999;  29 736-741
    PubMedGoogle Scholar
  • 37 Walker S C, Helm P A, Pullium G. Total contact casting and chronic diabetic neuropathic foot ulcerations: healing rates by wound location.  Arch Phys Med Rehabil. 1987;  68 217-223
    PubMedGoogle Scholar
  • 38 Mehta J A, Brown C, Sargeant N. Charcot restraint orthotic walker.  Foot Ankle Int. 1998;  19 619-624
    PubMedGoogle Scholar
  • 39 Morgan J M, Biehl III W C, Wagner F W. Management of neuropathic arthropathy with the Charcot Restraint Orthotic Walker.  Clin Orthop. 1993;  296 58-64
    PubMedGoogle Scholar
  • 40 Carter G T, Jensen M P, Galer B S et al.. Neuropathic pain in Charcot Marie Tooth disease.  Arch Phys Med Rehabil. 1998;  79 1560-1564
    CrossrefPubMedGoogle Scholar
  • 41 Moulin D E, Hagen N, Feasby T E, Amireh R, Hahn A. Pain in Guillain-Barre syndrome.  Neurology. 1997;  48 328-331
    CrossrefPubMedGoogle Scholar
  • 42 Carter G T, Galer B S. Advances in the management of neuropathic pain.  Phys Med Rehabil Clin N Am. 2001;  12 447-460
    CrossrefPubMedGoogle Scholar
  • 43 Abresch R T, Jensen M P, Carter G T. Health quality of life in peripheral neuropathy.  Phys Med Rehabil Clin N Am. 2001;  12 461-472
    PubMedGoogle Scholar
  • 44 Abresch R T, Carter G T, Jensen M P, Kilmer D D. Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease.  Am J Hosp Palliat Care. 2002;  19 39-48
    CrossrefPubMedGoogle Scholar
  • 45 Backonja M M. Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus.  Epilepsia. 1999;  40 S57-S59
    PubMedGoogle Scholar
  • 46 Beydoun A. Postherpetic neuralgia: role of gabapentin and other treatment modalities.  Epilepsia. 1999;  40 S51-S56
    PubMedGoogle Scholar
  • 47 Magnus L. Nonepileptic uses of gabapentin.  Epilepsia. 1999;  40 S66-S72
    PubMedGoogle Scholar
  • 48 McQuay H, Carroll D, Jadad A R et al.. Anticonvulsant drugs for management of pain: a systemic review.  BMJ. 1995;  311 1047-1052
    PubMedGoogle Scholar
  • 49 Morello C M, Leckband S G, Stoner C P et al.. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain.  Arch Intern Med. 1999;  159 1931-1937
    CrossrefPubMedGoogle Scholar
  • 50 Carter G T, Sullivan M D. Antidepressants in pain management.  Curr Opin Investig Drugs. 2002;  3 454-458
    PubMedGoogle Scholar
  • 51 Kingery W S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes.  Pain. 1997;  73 123-139
    CrossrefPubMedGoogle Scholar
  • 52 Max M B, Culnane M, Schafer S C et al.. Amitriptyline relieves diabetic neuropathy pain in patients with normal depressed mood.  Neurology. 1987;  37 589-596
    PubMedGoogle Scholar
  • 53 Max M B, Lynch S A, Muir J et al.. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.  N Engl J Med. 1992;  326 1250-1252
    CrossrefPubMedGoogle Scholar
  • 54 Watson C P, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial.  Neurology. 1998;  51 1166-1171
    PubMedGoogle Scholar
  • 55 Taylor K, Rowbotham M C. Venlafaxine hydrochloride and chronic pain.  West J Med. 1996;  165 147-148
    PubMedGoogle Scholar
  • 56 Galer B S, Harle J, Rowbotham M C. Response to intravenous lidocaine infusion predicts subsequent response to oral mexilitine: a prospective study.  J Pain Symptom Manage. 1996;  12 161-167
    CrossrefPubMedGoogle Scholar
  • 57 Galer B S, Miller K V, Rowbotham M C. Response to intravenous lidocaine differs based on clinical diagnosis and site of nervous system injury.  Neurology. 1993;  43 1233-1235
    PubMedGoogle Scholar
  • 58 Galer B S. Neuropathic pain of peripheral origin: advances in pharmacologic treatment.  Neurology. 1995;  45 17-25
    PubMedGoogle Scholar
  • 59 Galer B S, Rowbotham M C, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle patch: results of an enriched enrollment study.  Pain. 1999;  80 533-538
    CrossrefPubMedGoogle Scholar
  • 60 Galer B S. Painful polyneuropathy.  Neurol Clin. 1998;  16 791-812
    CrossrefPubMedGoogle Scholar
  • 61 Duhmke R M, Cornblath D D, Hollingshead J R. Tramadol for neuropathic pain.  Cochraine Database Syst Rev. 2004;  (2) CD003726
    PubMedGoogle Scholar
  • 62 Watson C P, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.  Neurology. 1998;  50 1837-1841
    PubMedGoogle Scholar
  • 63 Jay C, Shade S, Vizoso H et al.. The effect of smoked marijuana on chronic neuropathic and experimentally induced pain in HIV neuropathy: results of an open-label pilot study. Proceedings of the 11th Conference on Retroviruses and Opportunistic Infections. 2004 496: A243 (Abstract)
    Google Scholar
  • 64 Wade D T, Robson P, House H, Makela P, Aram J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.  Clin Rehabil. 2003;  17 21-29
    CrossrefPubMedGoogle Scholar
  • 65 Carter G T, Rosen B S. Marijuana in the management of amyotrophic lateral sclerosis.  Am J Hosp Palliat Care. 2001;  18 264-270
    PubMedGoogle Scholar
  • 66 Carter G T, Weydt P. Cannabis: old medicine with new promise for neurological disorders.  Curr Opin Investig Drugs. 2002;  3 437-440
    PubMedGoogle Scholar
  • 67 Robson P. Therapeutic aspects of cannabis and cannabinoids.  Br J Psychiatry. 2001;  178 98-105
    CrossrefPubMedGoogle Scholar
  • 68 Rice A SC. Cannabinoids and pain.  Curr Opin Investig Drugs. 2001;  2 399-414
    PubMedGoogle Scholar

Gregory T CarterM.D. 

1809 Cooks Hill Road

Centralia, WA 98531

      >